Post-marketing Safety Surveillance of Tofacitinib in UC Post-marketing Safety Surveillance of Tofacitinib in UC

This study evaluated the safety profile of tofacitinib in patients with ulcerative colitis in the post-marketing setting. Were adverse events consistent with those reported in clinical trials?Alimentary Pharmacology & Therapeutics
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news